Abstract Submission Form Guidelines
TERMIS-AP + ABMC7 2019 invites abstracts in all areas of tissue engineering, regenerative medicine, biomaterials, technology development and clinical translation. Abstracts with educational, career development and societal impact are also welcomed.
|Deadline for Abstract Submission||21 May 2019|
|Notification of Abstract Submission||14 June 2019|
|Author/Presenter Registration Deadline||30 June 2019|
|Deadline for Early Bird Registrations||17 July 2019|
TERMIS-AP + ABMC7 2019 assumes that all authors have approved the submitted abstract. All abstracts must be submitted online using the template format. All abstracts must be written in English.
TERMIS-AP + ABMC7 2019 accepts no responsibility for submitted abstracts. The responsibility remains with the authors. The copyright of all abstracts rests with the authors and TERMIS-AP + ABMC7 2019 may not be held responsible for any infringements as a result of plagiarism, libel, slander or any misuse of material. Authors submitting an abstract for the TERMIS-AP + ABMC7 2019 meeting do so with the understanding that they will abide by the conditions, deadline policies and decisions of the TERMIS-AP + ABMC7 2019 Committee.
If you have any questions regarding abstract submission, please contact the Congress Organisers at email@example.com.
Review Criteria and Notification
Submitted abstracts will be evaluated on the basis of the following criteria:
- Relevance to tissue engineering and regenerative medicine research;
- Scientific / technological / clinical / educational / societal impact.
Submitted abstracts will be reviewed and considered for oral or poster presentation.
Notification of acceptance or rejection will be communicated to the authors by 14 June 2019 AEST.
Abstracts are submitted with the understanding that when an abstract is accepted, the presenting author will register by 30 June 2019 AEST and attend the meeting. Should the presenting author be unable to attend the meeting, a registered co-author may present the oral or poster presentation instead.
PLEASE ADHERE TO THE ABSTRACT GUIDELINES BELOW:
- Abstracts must not exceed one page.
- Abstracts must be submitted in PDF format.
- All abstracts must be formatted for only A4 paper (210 x 297 mm).
- Margin sizes must not be altered and are set to 25 mm.
- The title should be in bold, 14 size Times New Romans font, center alignment.
- The author should be listed consecutively by initials and last name.
- The name (first name second name) and email of the presenting author must be indicated.
- Affiliation should be indicated with superscripted suffix Arabic numerals. Do not append degrees, professional designations, etc., to names.
- Affiliations should be listed consecutively.
- The body of the document should be set in size 11 Times New Roman, justified, with single line-spacing.
- Figures should have the caption below them.
- Tables should have the caption above them.
- References: A maximum of three references may be used. In the text, indicate references by number(s) in square brackets in line with the text (e.g. ). In the list, number the references (numbers in square brackets) in the order in which they appear in the text. Please use the following format:  Satyam A et al. Adv Mater. 2014; 26(19):3024-34
- The abstracts must not exceed 5MB in size.
- Rename the file using the presenting author’s first name second name (e.g. Diana Gaspar).
- Indicative example of formatted abstract is provided below. You may want to copy, paste special, unformatted text each section of your abstract in the respective sections of the example abstract below to maintain the present format.
- Please submit your abstract (PDF format only) via to online form by 11.59pm Tuesday 21 May 2019 AEST.
Students or Young Investigators wishing for their abstract to be considered for an award should nominate this within the submission form. Students and Young Investigators are also able to nominate themselves to be a co-chair in a session during the online submission process.
Student: Any individual who is engaged as a full-time undergraduate or graduate in a university or college program and is actively involved in research in the field of tissue engineering and regenerative medicine. You will be asked to submit a copy of your student identification card during the registration process.
Young Investigator: Any individual who is employed by an academic institution in the field of tissue engineering and regenerative medicine, who has been awarded their doctoral degree within the past 3 years and who is not holding an appointment as faculty or academic staff. Young investigators are required to have their advisor / supervisor send a letter as proof of the bona fide status of the young investigator.
TERMIS-AP + ABMC7 2019
INCLUSION, DIVERSITY AND GENDER EQUITY POLICY
The TERMIS-AP + ABMC7 2019 Congress strives to achieve inclusivity, diversity and gender balance in all aspects of the Congress. In all aspects of the Congress we shall endeavour to achieve this basic principle of balance through equal and diverse representation.
The TERMIS-AP + ABMC7 2019 Organising Committee are familiar with this policy and are diverse, informed, and gender balanced itself.
The Congress will report back to both hosting societies on the gender breakdown of the committee, invited speakers, regular speakers, and attendees.
TERMIS-AP + ABMC7 2019 is dedicated to providing a harassment-free environment for everyone, regardless of gender, gender identity, sexual orientation, disability, physical appearance, race, age or religion. We do not tolerate harassment of fellow member or Congress participants in any form. Members or Congress participants violating these rules may be sanctioned or expelled from the society and/or Congress.